Correlation Between Teva Pharma and Connect Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Connect Biopharma Holdings, you can compare the effects of market volatilities on Teva Pharma and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Connect Biopharma.

Diversification Opportunities for Teva Pharma and Connect Biopharma

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Teva and Connect is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Teva Pharma i.e., Teva Pharma and Connect Biopharma go up and down completely randomly.

Pair Corralation between Teva Pharma and Connect Biopharma

Given the investment horizon of 90 days Teva Pharma is expected to generate 1.34 times less return on investment than Connect Biopharma. But when comparing it to its historical volatility, Teva Pharma Industries is 3.64 times less risky than Connect Biopharma. It trades about 0.12 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  90.00  in Connect Biopharma Holdings on September 4, 2024 and sell it today you would earn a total of  18.00  from holding Connect Biopharma Holdings or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Teva Pharma Industries  vs.  Connect Biopharma Holdings

 Performance 
       Timeline  
Teva Pharma Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharma Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Teva Pharma and Connect Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharma and Connect Biopharma

The main advantage of trading using opposite Teva Pharma and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.
The idea behind Teva Pharma Industries and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.